UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Dravet syndrome: Treatment options and management of prolonged seizures

Cross, JH; Caraballo, RH; Nabbout, R; Vigevano, F; Guerrini, R; Lagae, L; (2019) Dravet syndrome: Treatment options and management of prolonged seizures. Epilepsia , 60 (S3) S39-S48. 10.1111/epi.16334. Green open access

[thumbnail of Article]
Preview
Text (Article)
Cross_Dravet syndrome_10082019.pdf - Accepted Version

Download (686kB) | Preview
[thumbnail of Figure 1]
Preview
Image (Figure 1)
Cross Figure 1.tif - Accepted Version

Download (332kB) | Preview
[thumbnail of Figure 2]
Preview
Image (Figure 2)
Cross Figure 2.tif - Accepted Version

Download (398kB) | Preview
[thumbnail of Figure 3]
Preview
Image (Figure 3)
Cross Figure 3.tif - Accepted Version

Download (253kB) | Preview

Abstract

Over time, with careful delineation of Dravet syndrome, we have gained experience in treatments most likely to lead to improvement in seizures, as well as those that should be avoided. Sodium valproate, clobazam, stiripentol, and topiramate are all medications that may lead to benefit, as well as the ketogenic diet. Bromides may be utilized in resistant cases. However, equally important are outlining prompt rescue treatment for prolonged seizures and avoidance of precipitants. Newer agents including cannabidiol and fenfluramine have been demonstrated to be of benefit in clinical trials. We propose an algorithm for management, but appreciate that the positioning of newer agents is yet to be established.

Type: Article
Title: Dravet syndrome: Treatment options and management of prolonged seizures
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/epi.16334
Publisher version: https://doi.org/10.1111/epi.16334
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: antiepileptic drugs, cannabidiol, Dravet syndrome, fenfluramine, stiripentol, treatment
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Developmental Neurosciences Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10091846
Downloads since deposit
715Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item